In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization for acute exacerbation of COPD and death than direct oral anticoagulants.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/vitamin-k-antagonists-may-not-worsen-copd-outcomes-2026a100047j?src=rss
Author :
Publish date : 2026-02-10 13:12:00
Copyright for syndicated content belongs to the linked Source.
